Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

HomeProduct name listSpiro[cyclohexane-1,1'(3'H)-pyrano[3,4-b]indol]-4-aMine, 6'-fluoro-4',9'-dihydro-N,N-diMethyl-4-phenyl-, cis- (9CI)

Spiro[cyclohexane-1,1'(3'H)-pyrano[3,4-b]indol]-4-aMine, 6'-fluoro-4',9'-dihydro-N,N-diMethyl-4-phenyl-, cis- (9CI)

  • CAS NO.:863513-93-3
  • Empirical Formula: C24H27FN2O
  • Molecular Weight: 378.49
  • MDL number: MFCD28386279
  • Update Date: 2025-10-28 16:00:23
Spiro[cyclohexane-1,1'(3'H)-pyrano[3,4-b]indol]-4-aMine, 6'-fluoro-4',9'-dihydro-N,N-diMethyl-4-phenyl-, cis- (9CI) Structural

What is Spiro[cyclohexane-1,1'(3'H)-pyrano[3,4-b]indol]-4-aMine, 6'-fluoro-4',9'-dihydro-N,N-diMethyl-4-phenyl-, cis- (9CI)?

Description

Cebranopadol ((1α,4α)stereoisomer) is a stereoisomer of cebranopadol. Cebranopadol is a potent agonist activity on ORL-1.

References

[1]. Schunk S, et al. Discovery of a Potent Analgesic NOP and Opioid Receptor Agonist: Cebranopadol. ACS Med Chem Lett. 2014 Jun 24;5(8):857-62.

Properties of Spiro[cyclohexane-1,1'(3'H)-pyrano[3,4-b]indol]-4-aMine, 6'-fluoro-4',9'-dihydro-N,N-diMethyl-4-phenyl-, cis- (9CI)

Boiling point: 547.5±50.0 °C(Predicted)
Density  1.23±0.1 g/cm3(Predicted)
storage temp.  Store at -20°C
solubility  Soluble in DMSO
pka 16.79±0.40(Predicted)
form  Solid
color  White to gray

Safety information for Spiro[cyclohexane-1,1'(3'H)-pyrano[3,4-b]indol]-4-aMine, 6'-fluoro-4',9'-dihydro-N,N-diMethyl-4-phenyl-, cis- (9CI)

Computed Descriptors for Spiro[cyclohexane-1,1'(3'H)-pyrano[3,4-b]indol]-4-aMine, 6'-fluoro-4',9'-dihydro-N,N-diMethyl-4-phenyl-, cis- (9CI)

You may like

Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.